In a move which is set to improve the nation’s health, Feisal Nahaboo founder and CEO of visionary pharmacy group Alitam has today announced plans to roll out a cutting-edge pharmacogenomics service within Alitam pharmacies, headed by the highly esteemed Alitam pharmacist, and one of the field’s leading pioneers, Professor Mark Ledwidge.
In a move which is set to improve the nation’s health, Feisal Nahaboo founder and CEO of visionary pharmacy group Alitam has today announced plans to roll out a cutting-edge pharmacogenomics service within Alitam pharmacies, headed by the highly esteemed Alitam pharmacist, and one of the field’s leading pioneers, Professor Mark Ledwidge.
Earlier this week, a lucrative equity sale made possible thanks to a revolutionary new type of merger (M&A) model made national headlines. This, however, did not come from the fast-paced tech sector as one might expect but, instead, the accountancy world, which is not typically associated with ground-breaking financial models.
Earlier this week, a lucrative equity sale made possible thanks to a revolutionary new type of merger (M&A) model made national headlines. This, however, did not come from the fast-paced tech sector as one might expect but, instead, the accountancy world, which is not typically associated with ground-breaking financial models.
Earlier this week, a lucrative equity sale made possible thanks to a revolutionary new type of merger (M&A) model made national headlines. This, however, did not come from the fast-paced tech sector as one might expect but, instead, the accountancy world, which is not typically associated with ground-breaking financial models.